TY - JOUR T1 - DTB Select: 2 | February 2017 JF - Drug and Therapeutics Bulletin JO - Drug Ther Bull SP - 14 LP - 17 DO - 10.1136/dtb.2017.2.0453 VL - 55 IS - 2 A2 - , Y1 - 2017/02/01 UR - http://dtb.bmj.com/content/55/2/14.abstract N2 - MHRA clarifies spironolactone advice ● Statin dosing: morning or evening? ● PPI use and risk of community-acquired pneumonia ● Non-inferiority trials: caution needed ● CV safety of celecoxib? ● ADRs and emergency department visits ● Study questions use of duloxetine in stress incontinence ● New oral anticoagulants: more on GI bleeding risk ER -